HealthPartners Medical Policy Updates – June 2021

Click here to view the HealthPartners Medical Policy Updates » 

June 2021 HealthPartners Medical Policy Updates: 

• Airway clearance system / chest compression generator system
• Airway clearance system/chest compression generator system – Minnesota Health Care Programs
• Breast and cervical cancer (BRCA) genetic mutation testing for breast and ovarian cancer susceptibility – Minnesota Health Care Programs – effective 9/1/2021
• Category III CPT codes
• Category III CPT codes – retire 9/1/2021
• Chimeric antigen receptor/genetically engineered T-cell receptor (CAR-T) therapy – Effective 5/1/2018
• Dental services – accidental dental
• Evinacumab-dgnb (Evkeeza™)
• General approach to genetic testing – effective 9/1/2021
• Genetic testing
• Genetic testing for aortopathies and connective tissue disorders – effective 9/1/2021
• Genetic Testing for Cancer Predisposition
• Genetic testing for cardiac disorders – effective 9/1/2021
• Genetic testing for epilepsy, neurodegenerative, and neuromuscular disorders – effective 9/1/2021
• Genetic testing for eye disorders – effective 9/1/2021
• Genetic testing for gastroenterologic disorders (non-cancerous) – effective 9/1/2021
• Genetic Testing for Gastrointestinal Disorders
• Genetic testing for hematologic disorders (non-cancerous) – effective 9/1/2021
• Genetic testing for hereditary cancer susceptibility – effective 9/1/2021
• Genetic testing for hereditary cancer susceptibility – Minnesota Health Care Programs – effective 9/1/2021
• Genetic testing for hereditary hearing loss – effective 9/1/2021
• Genetic testing for immune disorders – effective 9/1/2021
• Genetic testing for kidney disorders – effective 9/1/2021
• Genetic testing for lung disorders – effective 9/1/2021
• Genetic testing for metabolic, endocrine, and mitochondrial disorders – effective 9/1/2021
• Genetic testing for multisystem inherited disorders, intellectual disability, and developmental delay – effective 9/1/2021
• Genetic testing for prenatal and preconception carrier screening – effective 8/15/2021
• Genetic testing for prenatal diagnosis (via amniocentesis, CVS, or PUBS) and pregnancy loss – effective 8/15/2021
• Genetic Testing: Carrier Screening, Prenatal Screening, Prenatal Diagnosis, and Infertility Evaluation
• Genetic Testing: Coagulation Disorders and Cardiovascular Risk Assessments
• Genetic testing: exome and genome sequencing for the diagnosis of genetic disorders – effective 9/1/2021
• Genetic Testing: Molecular Profiling Assays for Cancer Management
• Genetic testing: non-invasive prenatal screening (NIPS) – effective 8/15/2021
• Genetic Testing: Pharmacogenetics
• Genetic testing: pharmacogenetics – effective 9/1/2021
• Home phototherapy-full body cabinet
• Home phototherapy-full body cabinet-Minnesota Health Care Programs
• Investigational services – list of non-covered services
• Lumasiran (Oxlumo™)
• Lurbinectedin injection (Zepzelca™) – Minnesota Health Care Plans
• Oncology: algorithmic testing – effective 9/1/2021
• Oncology: cancer screening – effective 9/1/2021
• Oncology: circulating tumor DNA and circulating tumor cells (liquid biopsy) – effective 9/1/2021
• Oncology: cytogenetic testing – effective 9/1/2021
• Oncology: molecular analysis of solid tumors and hematologic malignancies – effective 9/1/2021
• Oncology: molecular analysis of solid tumors and hematologic malignancies – Minnesota Health Care Programs – effective 9/1/2021
• Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf (Phesgo™) – Minnesota Health Care Plans
• Polatuzumab Vedotin-piiq (Polivy™) – Minnesota Health Care Programs
• Preimplantation genetic testing – effective 8/15/2021
• Preventive care services
• Recent Food and Drug Administration (FDA) approved medications coverage policy
• Repetitive transcranial magnetic stimulation
• Residential – Psychiatric residential treatment facility (PRTF) – Minnesota Health Care Programs
• Reslizumab (Cinqair®)
• Rhinoplasty & septorhinoplasty
• Supprelin LA/Lupron Depot-Peds – Minnesota Health Care Programs
• Tafasitamab-cxix (Monjuvi®) – Minnesota Health Care Programs
• Talimogene laherparepvec (Imlygic®) – Minnesota Health Care Programs
• Temporomandibular Disorder (TMD) Treatments
• Trabectedin (Yondelis®) – Minnesota Health Care Programs
• Vision therapy / orthoptics and pleoptics – Minnesota Health Care Programs

Click here to view the HealthPartners Medical Policy Updates »

HealthPartners

Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!

Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.